Dr. Anastasios Manessis, MD
- Medicare services, 2024
- 25,972
- Medicare patients, 2024
- 1,331
- Part D claims, 2024
- 12,876
- Publications
- 8
- Clinical trials
- 22
- Practice address
- 36-36 33rd St, Astoria, NY 11106
- Practice phone
- Call (718) 704-5376
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Endocrine Associate of West Village
Astoria, New York
Find Dr. Manessis' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Anastasios Manessis is an endocrinologist in Astoria, New York
Dr. Manessis practices at Endocrine Associate of West Village in Astoria, New York.
Dr. Manessis' NPI, 1467615823, was assigned on July 7, 2008. Dr. Manessis graduated from Jacobs School of Medicine and Biomedical Sciences in 2001. Dr. Manessis holds New York license 235572.
- NPI
- 1467615823NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0446324438
- NPI enumeration date
- July 7, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (718) 704-5376
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Anastasios Manessis practices at Endocrine Associate of West Village in Astoria, New York
Dr. Manessis' primary practice is Endocrine Associate of West Village, at 36-36 33rd St, Astoria, NY 11106 in Queens County. The practice phone is (718) 704-5376.
- Endocrine Associate of West Village36-36 33rd St, Astoria, NY 11106 · Queens CountyPhone(718) 704-5376
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Anastasios Manessis is affiliated with 3 sites of care and 2 medical groups
Dr. Manessis' primary practice is Endocrine Associate of West Village in Astoria, New York. Dr. Manessis is also affiliated with Tisch Hospital. The medical group on file is SOMOS Medical PC. Dmand AI also links Dr. Manessis to 1 more group practice or clinic and 1 medical group, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Anastasios Manessis' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manessis practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Endocrine Associate of West Village | Available with a free account |
| +2 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Anastasios Manessis is one of 835 endocrinologists in New York
Endocrinology, diabetes and metabolism is Dr. Manessis' primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Manessis is board certified in endocrine certification in neck ultrasound by the American Association of Clinical Endocrinologist. Dr. Manessis is licensed in New York.
Specialties and state licenses
- Endocrinology, diabetes and metabolism, New YorkPrimary
Clinical focus
Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, hypercalcemia, obesity, osteoporosis and overactive thyroid among the conditions Dr. Manessis treats.
Endocrinologists near Dr. Manessis
Counts of endocrinologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Anastasios Manessis billed Medicare for 25,972 services in 2024
CMS data shows 25,972 Medicare services from Dr. Manessis across 60 procedure codes in 2024, for 1,331 Medicare patients. Medicare paid $1,040,979 for them. Every service was in an office.
Dr. Manessis' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Lab and pathology
- 2023: 9,7422024: 11,23815%
- Office and hospital visits
- 2023: 10,1092024: 11,0419%
- Tests and treatments
- 2023: 1,3452024: 1,66524%
- Surgery
- 2023: 1,1982024: 1,2595%
- Other services
- 2023: 4122024: 45611%
- Imaging
- 2023: 3122024: 2946%
- Drugs given in the office
- 2023: 872024: 1978%
Dr. Manessis compared with the New York median for endocrinologists, 2024
- Dr. Manessis
- New York median
- Medicare services
- 25,972vs 61342.4 times
- Medicare patients
- 1,331vs 2405.5 times
- Part D claims
- 12,050vs 1,3568.9 times
Medians across 816 endocrinologists in New York with Dmand AI profiles that report each measure.
Dr. Manessis' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Manessis?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Manessis and other endocrinologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Anastasios Manessis treated 1,331 Medicare patients in 2024, average age 73
CMS counts 1,331 Medicare patients who saw Dr. Manessis in 2024. The largest group is 65 to 74, with 607 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Manessis' median patient age at 55, with 61% women.
Dr. Manessis' Medicare patients by age, 2024
Dr. Manessis' Medicare patients by sex, 2024
- Women81861%
- Men51339%
Chronic conditions among Dr. Manessis' Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Diabetes74%
- Arthritis50%
- Ischemic heart disease37%
- Chronic kidney disease24%
- Osteoporosis24%
- Mood disorders22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Manessis' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 55
Patient panel by sex, all payers
- Women61%
- Men35%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Anastasios Manessis wrote 12,876 Medicare Part D claims in 2024
In 2024, Dr. Manessis wrote 12,876 Medicare Part D claims for 1,587 patients. 36% of them were for generic drugs. CMS names the drug for 12,050 of them, across 126 drugs with 11 or more claims each, at $6,461,891 in total drug cost. In 2023, CMS named 10,748 claims across 116 drugs.
Dr. Manessis' Part D claims by kind of drug, 2024
- Generic4,696 claims36%
- Brand-name7,086 claims55%
- Other1,094 claims8%
Dr. Manessis' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Manessis' Part D claims, 2024
- Antibiotics0%37 of 12,876 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 10,7482024: 12,05012%
Drugs named by CMS: 126 in 2024, 116 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Anastasios Manessis scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Manessis for performance year 2024, reported individually. Dr. Manessis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manessis as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Manessis' MIPS scores, performance year 2024
- 100of 100Final score
- 100of 100Quality
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)
Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Anastasios Manessis has 8 publications on record
Dmand AI links 8 papers to Dr. Manessis in 2024. The most frequent topics are Administration, Inhalation, Blood Glucose and Insulin. Dr. Manessis has published most often in Diabetes Care. Dr. Manessis' most frequent co-authors are Halis Kaan Akturk, MD, Thomas C. Blevins, MD and Irl B. Hirsch.
Topics Dr. Manessis writes about most
- Administration, Inhalation
- Blood Glucose
- Insulin
- Diabetes Mellitus, Type 1
- Hypoglycemic Agents
- Glycated Hemoglobin
- Insulin, Long-Acting
Dr. Manessis' most frequent co-authors
- Halis Kaan Akturk, MD3 shared papers
- Thomas C. Blevins, MD3 shared papers
- Irl B. Hirsch3 shared papers
Recent publications by Dr. Manessis
JPEN J Parenter Enteral Nutr
Diabetes Technol Ther
See who Dr. Manessis researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Manessis works with, so you can find a warm path to the right endocrinologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Anastasios Manessis has worked on 22 clinical trials
Dmand AI links Dr. Manessis to 22 clinical trials, 7 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Diabetes Mellitus, Type 2, Diabetes Mellitus and Diabetes Mellitus, Type 1. Sanofi sponsors the most, 6. Open Payments lists research payments to Dr. Manessis that name 7 trials.
Clinical trials with Dr. Manessis by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 7Phase 3: 7 trials
- 1Phase 4: 1 trial
Conditions in Dr. Manessis' trials
- Diabetes Mellitus, Type 2
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Autoimmune Diseases
- Hypertriglyceridemia
Investigators on the most trials with Dr. Manessis
- Julio Rosenstock, MD7 shared trials
- Amer S. Al-Karadsheh, MD5 shared trials
- Timothy Silleck Bailey, MD5 shared trials
Recent clinical trials with Dr. Manessis
Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia (opens in a new tab)
Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes (opens in a new tab)
Eversense® Non-adjunctive Use Post Approval Study (opens in a new tab)
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Anastasios Manessis received $793,573 in industry payments from 2016 to 2025
CMS Open Payments shows 2,292 general payments to Dr. Manessis from 73 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Novo Nordisk Inc paid the most, $186,389. It also lists 12 research payments totaling $125,780 from 2017 to 2024, naming 7 clinical trials.
General payments to Dr. Manessis by program year, 2016 to 2025
General payments to Dr. Manessis by kind, 2016 to 2025
- Speaker and faculty fees$659,72483%
- Food and beverage$58,7547%
- Consulting fees$44,5766%
- Travel and lodging$28,8204%
- Other$1,5800%
Companies that paid Dr. Manessis the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Anastasios Manessis has 5 awards and honors on record
Dmand AI lists 5 awards for Dr. Manessis, most recently Fellow of American College of Endocrinology in 2015.
Awards and honors for Dr. Manessis
- 2015
- Fellow of American College of Endocrinology
- 2014
- Best of Queens
- 2013
- Most Compassionate Doctor
- 2012
- Americas Top Physicians
- Honored Member
Source: Dmand AI Professional Profile Data
Dr. Anastasios Manessis graduated from Jacobs School of Medicine and Biomedical Sciences
Dr. Manessis graduated from Jacobs School of Medicine and Biomedical Sciences in 2001. Dr. Manessis is a member of AACE, ADA, AIUM, AMA, APMA and ATA.
- Medical school
- Board certified in endocrine certification in neck ultrasound
- Board certified in obesity medicine
Source: Dmand AI Professional Profile Data
Dr. Anastasios Manessis accepts plans from 16 insurance carriers
Dr. Manessis is in network with 16 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Aetna
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Michigan
- HCSC
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- Humana
- +8 more carriersWith a free account
Plan types Dr. Manessis accepts, by number of carriers
- Medicare10
- PPO10
- HMO7
- POS5
- EPO4
- Medicaid3
Source: Dmand AI Insurance Network Data
Sources for Dr. Anastasios Manessis's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Anastasios Manessis
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Anastasios Manessis' NPI number?
Dr. Anastasios Manessis' NPI number is 1467615823. It was assigned on July 7, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Anastasios Manessis?
Dr. Anastasios Manessis is an endocrinologist in Astoria, New York. The primary specialty in the NPI Registry is Endocrinology, Diabetes & Metabolism Physician (taxonomy code 207RE0101X).
Where does Dr. Anastasios Manessis practice?
Dr. Manessis practices at 36-36 33rd St, Astoria, NY 11106. Dr. Manessis' primary practice is Endocrine Associate of West Village in Astoria, New York. Dmand AI also links Dr. Manessis to 1 group practice or clinic and 1 medical group.
What is Dr. Anastasios Manessis' office phone number?
The practice phone on file for Dr. Manessis is (718) 704-5376.
What is Dr. Anastasios Manessis' medical license number?
Dr. Manessis holds New York license 235572.
Which hospitals is Dr. Anastasios Manessis affiliated with?
Dr. Manessis is affiliated with Tisch Hospital.
What medical group is Dr. Anastasios Manessis part of?
Dr. Manessis is linked to SOMOS Medical PC. Dmand AI links Dr. Manessis to 1 more medical group.
Does Dr. Anastasios Manessis accept Medicare?
Yes. CMS data shows Dr. Manessis billed Medicare for 25,972 services in 2024, and Dr. Manessis accepts Medicare assignment.
Does Dr. Anastasios Manessis offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Manessis as offering telehealth services.
What is Dr. Anastasios Manessis' MIPS score?
Dr. Manessis' MIPS final score for performance year 2024 is 100 out of 100, reported individually.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Anastasios Manessis see?
CMS counts 1,331 Medicare patients who saw Dr. Manessis in 2024, with an average age of 73.
Is Dr. Anastasios Manessis board certified?
Yes. Dr. Manessis is board certified in endocrine certification in neck ultrasound by the American Association of Clinical Endocrinologist.
What services does Dr. Anastasios Manessis bill to Medicare?
In 2024, Dr. Manessis' most billed Medicare services were care management and other visits (99457), care management and other visits (99454) and care management and other visits (99424).
Where did Dr. Anastasios Manessis go to medical school?
Dr. Manessis graduated from Jacobs School of Medicine and Biomedical Sciences in 2001.
What drugs does Dr. Anastasios Manessis prescribe most?
In 2024 Medicare Part D data, Dr. Manessis' most prescribed drugs by claims were Mounjaro, Levothyroxine Sodium and Ozempic.
Has Dr. Anastasios Manessis received payments from drug or device companies?
CMS Open Payments shows $793,573 in general payments to Dr. Manessis from 73 companies from 2016 to 2025. The largest total came from Novo Nordisk Inc.
How long has Dr. Anastasios Manessis been practicing?
Dr. Manessis graduated from medical school in 2001, 25 years ago.
Does Dr. Anastasios Manessis do research?
Dmand AI links 8 publications to Dr. Manessis. Dr. Manessis has worked on 22 clinical trials.
Who does Dr. Anastasios Manessis publish with?
Dr. Manessis' most frequent co-authors are Halis Kaan Akturk, MD (3 shared papers), Thomas C. Blevins, MD (3 shared papers) and Irl B. Hirsch (3 shared papers).
What insurance does Dr. Anastasios Manessis accept?
Dr. Manessis is in network with 16 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to endocrinology, diabetes and metabolism practices?
See endocrinologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card